Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

Robert E.J. Ryder, Ralph A. DeFronzo

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Pioglitazone: inexpensive; very effective at reducing HbA<sub>1c</sub>; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit'. Together they form a unique fingerprint.